Cargando…

Adenovirus-Based Vectors for the Development of Prophylactic and Therapeutic Vaccines

Emerging and reemerging infectious diseases as well as cancer pose great global health impacts on the society. Vaccines have emerged as effective treatments to prevent or reduce the burdens of already developed diseases. This is achieved by means of activating various components of the immune system...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borovjagin, Anton V., Gomez-Gutierrez, Jorge G., Shirwan, Haval, Matthews, Qiana L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121347/ http://dx.doi.org/10.1007/978-3-7091-1818-4_8

Ejemplares similares

Current progress in the development of a prophylactic vaccine for HIV-1
por: Gamble, Lena J, et al.
Publicado: (2010)

A Novel Vaccine Approach for Chagas Disease Using Rare Adenovirus Serotype 48 Vectors
por: Farrow, Anitra L., et al.
Publicado: (2016)

HIV Antigen Incorporation within Adenovirus Hexon Hypervariable 2 for a Novel HIV Vaccine Approach
por: Matthews, Qiana L., et al.
Publicado: (2010)

Co-stimulatory tumor necrosis factor ligands as adjuvants for the development of subunit-based anticancer vaccines
por: Shirwan, Haval, et al.
Publicado: (2013)

A DNA Vaccine Encoding SA-4-1BBL Fused to HPV-16 E7 Antigen Has Prophylactic and Therapeutic Efficacy in a Cervical Cancer Mouse Model
por: Garza-Morales, Rodolfo, et al.
Publicado: (2019)

Development of nonhuman adenoviruses as vaccine vectors
por: Bangari, Dinesh S., et al.
Publicado: (2006)

Development of replication-competent adenovirus based vaccine vectors
por: Abbink, P, et al.
Publicado: (2012)

Adenoviruses as vaccine vectors
por: Tatsis, Nia, et al.
Publicado: (2004)

Metabolome-Driven Regulation of Adenovirus-Induced Cell Death
por: Laevskaya, Anastasia, et al.
Publicado: (2021)

Adenovirus Vectors: Excellent Tools for Vaccine Development
por: Chang, Jun
Publicado: (2021)

Simian adenoviruses as vaccine vectors
por: Morris, Susan J, et al.
Publicado: (2016)

COVID-19 Vaccines Based on Adenovirus Vectors
por: Hasanpourghadi, Mohadeseh, et al.
Publicado: (2021)

Adenovirus vector-based vaccine for infectious diseases
por: Sakurai, Fuminori, et al.
Publicado: (2022)

Using Multivalent Adenoviral Vectors for HIV Vaccination
por: Gu, Linlin, et al.
Publicado: (2013)

Development of a novel simian adenovirus 24 based vaccine vector
por: Abbink, P, et al.
Publicado: (2012)

CD4(+) T Cells Play a Critical Role in the Generation of Primary and Memory Antitumor Immune Responses Elicited by SA-4-1BBL and TAA-Based Vaccines in Mouse Tumor Models
por: Sharma, Rajesh K., et al.
Publicado: (2013)

Derivation of a Triple Mosaic Adenovirus for Cancer Gene Therapy
por: Tang, Yizhe, et al.
Publicado: (2009)

Perspective on Adenoviruses: Epidemiology, Pathogenicity, and Gene Therapy
por: Crenshaw, Brennetta J., et al.
Publicado: (2019)

A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the “Antigen Capsid-Incorporation” strategy
por: Gu, Linlin, et al.
Publicado: (2014)

Oncolytic adenoviruses: A thorny path to glioma cure
por: Ulasov, I.V., et al.
Publicado: (2014)

Tumor cells engineered to codisplay on their surface 4-1BBL and LIGHT costimulatory proteins as a novel vaccine approach for cancer immunotherapy
por: Sharma, Rajesh Kumar, et al.
Publicado: (2010)

Pre-Clinical Development of an Adenovirus Vector Based RSV and Shingles Vaccine Candidate
por: Petherbridge, Lawrence, et al.
Publicado: (2023)

Fas/Fas-Ligand Interaction As a Mechanism of Immune Homeostasis and β-Cell Cytotoxicity: Enforcement Rather Than Neutralization for Treatment of Type 1 Diabetes
por: Yolcu, Esma S., et al.
Publicado: (2017)

Mechanisms of Tolerance Induction by Hematopoietic Chimerism: The Immune Perspective
por: Yolcu, Esma S., et al.
Publicado: (2017)

Development of an adenovirus vector vaccine platform for targeting dendritic cells
por: Sharma, Piyush K, et al.
Publicado: (2017)

Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections
por: Koger-Pease, Cal, et al.
Publicado: (2023)

Current progress in the development of prophylactic and therapeutic vaccines
por: Li, Tingting, et al.
Publicado: (2022)

4-1BB Signaling in Conventional T Cells Drives IL-2 Production That Overcomes CD4(+)CD25(+)FoxP3(+) T Regulatory Cell Suppression
por: Barsoumian, Hampartsoum B., et al.
Publicado: (2016)

Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens
por: Afkhami, Sam, et al.
Publicado: (2016)

Adenoviruses as vectors for delivering vaccines to mucosal surfaces
por: Babiuk, L.A, et al.
Publicado: (2000)

Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approach
por: Matthews, Qiana L, et al.
Publicado: (2008)

Cytokine Responses to Adenovirus and Adenovirus Vectors
por: Atasheva, Svetlana, et al.
Publicado: (2022)

A modified surgical procedure using minimally invasive ileocolic vein perfusion in a mouse intrahepatic islet transplant model
por: Zhang, Lei, et al.
Publicado: (2022)

Prophylactic and therapeutic vaccines for obesity
por: Na, Ha-Na, et al.
Publicado: (2014)

Aerosolized adenovirus-vectored vaccine as an alternative vaccine delivery method
por: Roy, Chad J, et al.
Publicado: (2011)

P17-27. Development of recombinant adenovirus 28 vectors for HIV vaccines
por: Ko, S, et al.
Publicado: (2009)

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
por: Ulaszewska, Marta, et al.
Publicado: (2023)

Adenovirus Gene Transfer to Amelogenesis Imperfecta Ameloblast-Like Cells
por: Borovjagin, Anton V., et al.
Publicado: (2011)

Construction and immune effect of an HPV16/18/58 trivalent therapeutic adenovirus vector vaccine
por: Wan, Bing, et al.
Publicado: (2022)

Measurement of Adenovirus-Based Vector Heterogeneity
por: Hickey, John M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1bqrqnjao01uhijfqffhnipqnj